Approval · Notice of Compliance 3731 · 1997
ANZEMET: Notice of Compliance 3731
Issued May 21, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3731
- Date
- May 21, 1997
- Company
- Hoechst Marion Roussel Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antiemetic
Products in this notice
Medicinal ingredients
- DOLASETRON MESYLATE 20 MG per ML
- DOLASETRON MESYLATE 50 MG per TAB
- DOLASETRON MESYLATE 100 MG per TAB